In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Yakult Honsha Co. Ltd.

www.yakult.co.jp

Latest From Yakult Honsha Co. Ltd.

Deal Watch, Focus On Asia: Cipla Licenses India Rights To Lilly’s Basalgar

Cipla expands on its in-licensing strategy in India with Lilly’s insulin glargine product, while Aptose signs second agreement with CrystalGenomics to add Chinese rights for leukemia candidate CG-806, and Yakult gains Japanese rights to Verastem's duvelisib.

Asia Pacific Deals

Pipeline Watch: Phase III Updates For Eravacycline, Opdivo And Keytruda

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Pipeline Watch Approvals

Recommendation edges Pomalyst closer to Japan launch

Japan has issued approval recommendations and other regulatory decisions for a batch of drugs including Celgene's myeloma therapy Pomalyst (pomalidomide), which now looks set to be approved and possibly launched in the country within the next few months.

Metabolic Disorders Cardiovascular

Recommendation Edges Pomalyst Closer To Japan Launch

Japan has issued approval recommendations and other regulatory decisions for a batch of drugs including Celgene's myeloma therapy Pomalyst, which now looks set to be approved and possibly launched in the country within the next few months.

BioPharmaceutical Japan
See All

Company Information

  • Industry
  • Diversified
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Yakult Honsha Co. Ltd.
  • Senior Management
  • Takashige Negishi, Pres.
  • Contact Info
  • Yakult Honsha Co. Ltd.
    Phone: (81) 3 3574 8960
    1-19 Higashi Shimbashi, 1-Chome
    Minato-Ku
    Tokyo, 105-8960
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register